Harnessing NAD Metabolism As Therapy for Cardiometabolic Diseases

Overview

Journal Curr Heart Fail Rep

Publisher Current Science

Date 2022 May 13

PMID 35556214

Authors

Akash Chakraborty

Keaton E Minor

Hina Lateef Nizami

Ying Ann Chiao

Chi Fung Lee

Affiliations

Soon will be listed here.

Abstract

Purpose Of The Review: This review summarizes current understanding on the roles of nicotinamide adenine dinucleotide (NAD) metabolism in the pathogeneses and treatment development of metabolic and cardiac diseases.

Recent Findings: NAD was identified as a redox cofactor in metabolism and a co-substrate for a wide range of NAD-dependent enzymes. NAD redox imbalance and depletion are associated with many pathologies where metabolism plays a key role, for example cardiometabolic diseases. This review is to delineate the current knowledge about harnessing NAD metabolism as potential therapy for cardiometabolic diseases. The review has summarized how NAD redox imbalance and depletion contribute to the pathogeneses of cardiometabolic diseases. Therapeutic evidence involving activation of NAD synthesis in pre-clinical and clinical studies was discussed. While activation of NAD synthesis shows great promise for therapy, the field of NAD metabolism is rapidly evolving. Therefore, it is expected that new mechanisms will be discovered as therapeutic targets for cardiometabolic diseases.

Citing Articles

Mitochondrial transplantation as a novel therapeutic strategy for cardiovascular diseases.

Sun M, Jiang W, Mu N, Zhang Z, Yu L, Ma H J Transl Med. 2023; 21(1):347.

PMID: 37231493 PMC: 10210445. DOI: 10.1186/s12967-023-04203-6.

Sexually dimorphic effects of SARM1 deletion on cardiac NAD metabolism and function.

Nizami H, Minor K, Chiao Y, Light C, Lee C Am J Physiol Heart Circ Physiol. 2022; 323(4):H774-H781.

PMID: 36053750 PMC: 9529255. DOI: 10.1152/ajpheart.00370.2022.

References

Karamanlidis G, Lee C, Garcia-Menendez L, Kolwicz Jr S, Suthammarak W, Gong G . Mitochondrial complex I deficiency increases protein acetylation and accelerates heart failure. Cell Metab. 2013; 18(2):239-50. PMC: 3779647. DOI: 10.1016/j.cmet.2013.07.002. View

Zhang D, Hu X, Li J, Liu J, Bulte L, Wiersma M . DNA damage-induced PARP1 activation confers cardiomyocyte dysfunction through NAD depletion in experimental atrial fibrillation. Nat Commun. 2019; 10(1):1307. PMC: 6428932. DOI: 10.1038/s41467-019-09014-2. View

Sundaresan N, Gupta M, Kim G, Rajamohan S, Isbatan A, Gupta M . Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J Clin Invest. 2009; 119(9):2758-71. PMC: 2735933. DOI: 10.1172/JCI39162. View

Uddin G, Youngson N, Doyle B, Sinclair D, Morris M . Nicotinamide mononucleotide (NMN) supplementation ameliorates the impact of maternal obesity in mice: comparison with exercise. Sci Rep. 2017; 7(1):15063. PMC: 5678092. DOI: 10.1038/s41598-017-14866-z. View

Huang D, Camacho C, Setlem R, Ryu K, Parameswaran B, Gupta R . Functional Interplay between Histone H2B ADP-Ribosylation and Phosphorylation Controls Adipogenesis. Mol Cell. 2020; 79(6):934-949.e14. PMC: 7502539. DOI: 10.1016/j.molcel.2020.08.002. View

Wang L, Miao L, Wang X, Huang C, Qian Y, Huang X . CD38 deficiency suppresses adipogenesis and lipogenesis in adipose tissues through activating Sirt1/PPARγ signaling pathway. J Cell Mol Med. 2017; 22(1):101-110. PMC: 5742727. DOI: 10.1111/jcmm.13297. View

Su H, Zeng H, Liu B, Chen J . Sirtuin 3 is essential for hypertension-induced cardiac fibrosis via mediating pericyte transition. J Cell Mol Med. 2020; 24(14):8057-8068. PMC: 7348169. DOI: 10.1111/jcmm.15437. View

Planavila A, Iglesias R, Giralt M, Villarroya F . Sirt1 acts in association with PPARα to protect the heart from hypertrophy, metabolic dysregulation, and inflammation. Cardiovasc Res. 2010; 90(2):276-84. DOI: 10.1093/cvr/cvq376. View

Boslett J, Reddy N, Alzarie Y, Zweier J . Inhibition of CD38 with the Thiazoloquin(az)olin(on)e 78c Protects the Heart against Postischemic Injury. J Pharmacol Exp Ther. 2019; 369(1):55-64. PMC: 6413770. DOI: 10.1124/jpet.118.254557. View

10.

Hirschey M, Shimazu T, Goetzman E, Jing E, Schwer B, Lombard D . SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature. 2010; 464(7285):121-5. PMC: 2841477. DOI: 10.1038/nature08778. View

11.

Wu J, Jin Z, Zheng H, Yan L . Sources and implications of NADH/NAD(+) redox imbalance in diabetes and its complications. Diabetes Metab Syndr Obes. 2016; 9:145-53. PMC: 4869616. DOI: 10.2147/DMSO.S106087. View

12.

Dollerup O, Christensen B, Svart M, Schmidt M, Sulek K, Ringgaard S . A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects. Am J Clin Nutr. 2018; 108(2):343-353. DOI: 10.1093/ajcn/nqy132. View

13.

Tanno M, Kuno A, Horio Y, Miura T . Emerging beneficial roles of sirtuins in heart failure. Basic Res Cardiol. 2012; 107(4):273. PMC: 3390697. DOI: 10.1007/s00395-012-0273-5. View

14.

Houghton M, Kerimi A, Tumova S, Boyle J, Williamson G . Quercetin preserves redox status and stimulates mitochondrial function in metabolically-stressed HepG2 cells. Free Radic Biol Med. 2018; 129:296-309. DOI: 10.1016/j.freeradbiomed.2018.09.037. View

15.

Guse A . Regulation of calcium signaling by the second messenger cyclic adenosine diphosphoribose (cADPR). Curr Mol Med. 2004; 4(3):239-48. DOI: 10.2174/1566524043360771. View

16.

Trammell S, Weidemann B, Chadda A, Yorek M, Holmes A, Coppey L . Nicotinamide Riboside Opposes Type 2 Diabetes and Neuropathy in Mice. Sci Rep. 2016; 6:26933. PMC: 4882590. DOI: 10.1038/srep26933. View

17.

Whitson J, Bitto A, Zhang H, Sweetwyne M, Coig R, Bhayana S . SS-31 and NMN: Two paths to improve metabolism and function in aged hearts. Aging Cell. 2020; 19(10):e13213. PMC: 7576234. DOI: 10.1111/acel.13213. View

18.

Zheng D, Zhang Y, Zheng M, Cao T, Wang G, Zhang L . Nicotinamide riboside promotes autolysosome clearance in preventing doxorubicin-induced cardiotoxicity. Clin Sci (Lond). 2019; 133(13):1505-1521. PMC: 6705112. DOI: 10.1042/CS20181022. View

19.

Chen T, Liu J, Li N, Wang S, Liu H, Li J . Mouse SIRT3 attenuates hypertrophy-related lipid accumulation in the heart through the deacetylation of LCAD. PLoS One. 2015; 10(3):e0118909. PMC: 4351969. DOI: 10.1371/journal.pone.0118909. View

20.

Shi W, Hegeman M, van Dartel D, Tang J, Suarez M, Swarts H . Effects of a wide range of dietary nicotinamide riboside (NR) concentrations on metabolic flexibility and white adipose tissue (WAT) of mice fed a mildly obesogenic diet. Mol Nutr Food Res. 2017; 61(8). PMC: 5573990. DOI: 10.1002/mnfr.201600878. View